IRVINE, Calif.--(BUSINESS WIRE)--May 16, 2019--
Masimo
(NASDAQ: MASI) is hosting an Investor Day at its headquarters in Irvine
today, which will include presentations by Chairman and Chief Executive
Officer Joe Kiani and other members of the executive team. A live
audiocast of the presentations and accompanying slides will be available
on the Investor Relations section at www.masimo.com.
About Masimo
Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive
monitoring technologies. Our mission is to improve patient outcomes and
reduce the cost of care by taking noninvasive monitoring to new sites
and applications. In 1995, the company debuted Masimo SET®
Measure-through Motion and Low Perfusion™ pulse oximetry,
which has been shown in multiple studies to significantly reduce false
alarms and accurately monitor for true alarms. Masimo SET® is
estimated to be used on more than 100 million patients in leading
hospitals and other healthcare settings around the world. In 2005,
Masimo introduced rainbow® Pulse CO-Oximetry technology,
allowing noninvasive and continuous monitoring of blood constituents
that previously could only be measured invasively, including total
hemoglobin (SpHb®), oxygen content (SpOC™),
carboxyhemoglobin (SpCO®), methemoglobin (SpMet®),
and more recently, Pleth Variability Index (PVI®) and Oxygen
Reserve Index (ORI™), in addition to SpO2, pulse rate and
perfusion index (PI). In 2014, Masimo introduced Root®, an
intuitive patient monitoring and connectivity platform with the Masimo
Open Connect™ (MOC-9™) interface. Masimo is also
taking an active leadership role in mHealth with products such as the
Radius-7™ wearable patient monitor and the MightySat™
fingertip pulse oximeter. Additional information about Masimo and its
products may be found at www.masimo.com.
Masimo, SET, Signal Extraction Technology, Improving Patient Outcome
and Reducing Cost of Care... by Taking Noninvasive Monitoring to New
Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI and ORI
are trademarks or registered trademarks of Masimo Corporation
View source version on businesswire.com: https://www.businesswire.com/news/home/20190516005257/en/
Source: Masimo
Investor Contact: Eli Kammerman
(949) 297-7077
[email protected]
Media Contact: Irene Paigah
(858) 859-7001
[email protected]